← FDA Drug Approvals (Drugs@FDA)
NEOPROFEN
NDA · New Drug Application · Sponsor: RECORDATI RARE · Approved 2006-04-13
Drug application
- FDA Application #
NDA021903- Application type
- New Drug Application
- Brand name
- NEOPROFEN
- Generic name
- IBUPROFEN LYSINE
- Active ingredients
- IBUPROFEN LYSINE
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- RECORDATI RARE
- Manufacturer
- Recordati Rare Diseases Inc.
- First approval
- 2006-04-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown